The demand for large-bore access to the femoral artery is increasing rapidly with rise of procedures like Transcatheter Aortic Valve Replacement (TAVR), Percutaneous Endovascular Aortic Aneurysm Repair (PEVAR), and Cardiac Support with Percutaneous Ventricular Assist Device (pVAD). 
Many of these patients will require additional procedures in their lifetime such Valve-in-Valve TAVR and/or coronary interventions which require an unobstructed access to the femoral artery. We are developing QuattroClose—Ultilizing Halo-Lock ™  which will support the patients’ lifetime management even in challenging calcified arteries. 
Our commitment lies in securing a seamless future for large-bore closure.


Biotechnology

Secure Closure Inc

Org chart

Teams

Offices